{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:11:42Z","timestamp":1697433102013},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.5414\/cpp45237","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T08:04:59Z","timestamp":1301040299000},"page":"237-243","source":"Crossref","is-referenced-by-count":13,"title":["Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a"],"prefix":"10.5414","volume":"45","author":[{"given":"J.","family":"Graff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Picard-Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T09:48:27Z","timestamp":1378460907000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=1581&doi=10.5414\/CPP45237&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":0,"journal-issue":{"issue":"04","published-print":{"date-parts":[[2007]]}},"alternative-id":["45237"],"URL":"https:\/\/doi.org\/10.5414\/cpp45237","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}